Home / Congress Presentations / Geographic Atrophy / Kongress der Schweizerischen Ophthalmologischen Gesellschaft (SOG) 2024
Kongress der Schweizerischen Ophthalmologischen Gesellschaft (SOG) 2024
Long-Term Efficacy and Safety of Pegcetacoplan Over 36 Months Including 12-Month Results of the GALE Open-Label Extension Study
Eyes on Geographic Atrophy: Setting the course for the future
The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.